The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates
Open accessAbstract
Ageing is the greatest risk factor for the development of Parkinson's disease. However, the current dogma holds that cellular mechanisms that are associated with ageing of midbrain dopamine neurons and those that are related to dopamine neuron degeneration in Parkinson's disease are unrelated. We propose, based on evidence from studies of non-human primates, that normal ageing and the degeneration of dopamine neurons in Parkinson's disease are linked by the same cellular mechanisms and, therefore, that markers of cellular risk factors accumulate with age in a pattern that mimics the pattern of degeneration observed in Parkinson's disease. We contend that ageing induces a pre-parkinsonian state, and that the cellular mechanisms of dopamine neuron demise during normal ageing are accelerated or exaggerated in Parkinson's disease through a combination of genetic and environmental factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024 · cited 1×
“The ubiquitylation of α-synuclein within Lewy bodies suggests a connection with the proteasome, and α-synuclein is a known substrate of chaperone-mediated autophagy involving the lysosom”
BackgroundFamilial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024
Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's Disease
Kish, S. J., Shannak, K., & Hornykiewicz, O. (1988) · New England Journal of Medicine · doi:10.1056/nejm198804073181402 · Cited by 1,953
The substantia nigra of the human brain
Damier, P., Hirsch, E. C., Agid, Y., & Graybiel, A. M. (1999) · Brain · doi:10.1093/brain/122.8.1437 · Cited by 1,756
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
Bender, A., Krishnan, K. J., Morris, C. M., Taylor, G. A., Reeve, A. K., Perry, R. H., Jaros, E., Hersheson, J. S., Betts, J., Klopstock, T., et al. (2006) · Nature Genetics · doi:10.1038/ng1769 · Cited by 1,570
α-Synuclein Is Degraded by Both Autophagy and the Proteasome
Webb, J. L., Ravikumar, B., Atkins, J., Skepper, J. N., & Rubinsztein, D. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300227200 · Cited by 1,429
Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease
Dexter, D. T., Carter, C. J., Wells, F. R., Javoy‐Agid, F., Agid, Y., Lees, A., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09133.x · Cited by 1,397
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183
Brunk, U. T., & Terman, A. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00959-0 · Cited by 919
Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age
Corral-Debrinski, M., Horton, T., Lott, M. T., Shoffner, J. M., Flint Beal, M., & Wallace, D. C. (1992) · Nature Genetics · doi:10.1038/ng1292-324 · Cited by 890
Kraytsberg, Y., Kudryavtseva, E., McKee, A. C., Geula, C., Kowall, N. W., & Khrapko, K. (2006) · Nature Genetics · doi:10.1038/ng1778 · Cited by 887
Alam, Z. I., Jenner, A., Daniel, S. E., Lees, A. J., Cairns, N., Marsden, C. D., Jenner, P., & Halliwell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031196.x · Cited by 845
Imamura, K., Hishikawa, N., Sawada, M., Nagatsu, T., Yoshida, M., & Hashizume, Y. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0766-2 · Cited by 791
Brunk, U. T., & Terman, A. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.02869.x · Cited by 726
Prevalence of Parkinsonian Signs and Associated Mortality in a Community Population of Older People
Bennett, D. A., Beckett, L. A., Murray, A. M., Shannon, K. M., Goetz, C. G., Pilgrim, D. M., & Evans, D. A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601113340202 · Cited by 659
Epidemiology of parkinson’s disease
Tanner, C. M., & Goldman, S. M. (1996) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70259-0 · Cited by 640
Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease
Sulzer, D. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.009 · Cited by 587
The substantia nigra of the human brain
Damier, P., Hirsch, E. C., Agid, Y., & Graybiel, A. M. (1999) · Brain · doi:10.1093/brain/122.8.1421 · Cited by 578
Gibb, W. R., & Lees, A. J. (1991) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.54.5.388 · Cited by 574
Altered proteasomal function in sporadic Parkinson’s disease
St. P. McNaught, K., Belizaire, R., Isacson, O., Jenner, P., & Olanow, C. W. (2003) · Experimental Neurology · doi:10.1006/exnr.2002.8050 · Cited by 573
Alam, Z. I., Daniel, S. E., Lees, A. J., Marsden, D. C., Jenner, P., & Halliwell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031326.x · Cited by 547
Mosharov, E. V., Larsen, K. E., Kanter, E., Phillips, K. A., Wilson, K., Schmitz, Y., Krantz, D. E., Kobayashi, K., Edwards, R. H., & Sulzer, D. (2009) · Neuron · doi:10.1016/j.neuron.2009.01.033 · Cited by 534
Reduced BDNF mRNA Expression in the Parkinson's Disease Substantia Nigra
Howells, D. W., Porritt, M. J., Wong, J. Y. F., Batchelor, P. E., Kalnins, R., Hughes, A. J., & Donnan, G. A. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7483 · Cited by 513
Oxidative stress and protein aggregation during biological aging
Squier, T. C. (2001) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00139-5 · Cited by 508
Oxidative stress and inflammation in Parkinson's disease: is there a causal link?
Hald, A., & Lotharius, J. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.01.013 · Cited by 508
AETIOLOGY OF PARKINSON'S DISEASE
Calne, D., & William Langston, J. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90802-4 · Cited by 469
Glutathione peroxidase, glial cells and Parkinson's disease
Damier, P., Hirsch, E. C., Zhang, P., Agid, Y., & Javoy-Agid, F. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90175-f · Cited by 466
Axonal Transport Defects in Neurodegenerative Diseases
Morfini, G. A., Burns, M., Binder, L. I., Kanaan, N. M., LaPointe, N., Bosco, D. A., Brown, R. H., Brown, H., Tiwari, A., Hayward, L., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3463-09.2009 · Cited by 464
Self-citationClearance of α-Synuclein Oligomeric Intermediates via the Lysosomal Degradation Pathway
Lee, H.-J., Khoshaghideh, F., Patel, S., & Lee, S.-J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3809-03.2004 · Cited by 445
Glial pathology but absence of apoptotic nigral neurons in long‐standing Parkinson's disease
Banati, R. B., Daniel, S. E., & Blunt, S. B. (1998) · Movement Disorders · doi:10.1002/mds.870130205 · Cited by 431
Functional Decline in Parkinson Disease
Jankovic, J., & Kapadia, A. S. (2001) · Archives of Neurology · doi:10.1001/archneur.58.10.1611 · Cited by 427
Chu, Y., Dodiya, H., Aebischer, P., Olanow, C. W., & Kordower, J. H. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.05.023 · Cited by 421
Self-citationExpression of the histocompatibility glycoprotein HLA-DR in neurological disease
McGeer, P. L., Itagaki, S., & McGeer, E. G. (1988) · Acta Neuropathologica · doi:10.1007/bf00689592 · Cited by 420
Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain
Wei Soong, N., Hinton, D. R., Cortopassi, G., & Arnheim, N. (1992) · Nature Genetics · doi:10.1038/ng1292-318 · Cited by 414
Chu, Y., & Kordower, J. H. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.08.021 · Cited by 396
Self-citationIrizarry, M. C., Growdon, W., Gomez-isla, T., Newell, K., George, J. M., Clayton, D. F., & Hyman, B. T. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199804000-00005 · Cited by 394
Castaño, A., Herrera, A. J., Cano, J., & Machado, A. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70041584.x · Cited by 390
Reduced Vesicular Storage of Dopamine Causes Progressive Nigrostriatal Neurodegeneration
Caudle, W. M., Richardson, J. R., Wang, M. Z., Taylor, T. N., Guillot, T. S., McCormack, A. L., Colebrooke, R. E., Di Monte, D. A., Emson, P. C., & Miller, G. W. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0319-07.2007 · Cited by 388
Lipofuscin: Mechanisms of formation and increase with age
TERMAN, A., & BRUNK, U. T. (1998) · APMIS · doi:10.1111/j.1699-0463.1998.tb01346.x · Cited by 387
Chung, C. Y., Seo, H., Sonntag, K. C., Brooks, A., Lin, L., & Isacson, O. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi178 · Cited by 361
Genomic investigation of α‐synuclein multiplication and parkinsonism
Ross, O. A., Braithwaite, A. T., Skipper, L. M., Kachergus, J., Hulihan, M. M., Middleton, F. A., Nishioka, K., Fuchs, J., Gasser, T., Maraganore, D. M., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21380 · Cited by 342
Patterns of gliosis in alzheimer's disease and aging cerebrum
Beach, T. G., Walker, R., & McGeer, E. G. (1989) · Glia · doi:10.1002/glia.440020605 · Cited by 336
Mirza, B., Hadberg, H., Thomsen, P., & Moos, T. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00455-8 · Cited by 327
Parain, K., Murer, M. G., Yan, Q., Faucheux, B., Agid, Y., Hirsch, E., & Raisman-Vozari, R. (1999) · NeuroReport · doi:10.1097/00001756-199902250-00021 · Cited by 303
Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys
Emborg, M. E., Ma, S. Y., Mufson, E. J., Levey, A. I., Taylor, M. D., Brown, W. D., Holden, J. E., & Kordower, J. H. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19981116)401:2<253::aid-cne7>3.0.co;2-x · Cited by 300
Self-citationK-ATP channels promote the differential degeneration of dopaminergic midbrain neurons
Liss, B., Haeckel, O., Wildmann, J., Miki, T., Seino, S., & Roeper, J. (2005) · Nature Neuroscience · doi:10.1038/nn1570 · Cited by 299
Mogi, M., Togari, A., Kondo, T., Mizuno, Y., Komure, O., Kuno, S., Ichinose, H., & Nagatsu, T. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050028 · Cited by 282
Kish, S. J., Shannak, K., Rajput, A., Deck, J. H. N., & Hornykiewicz, O. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09766.x · Cited by 272
Lewy Bodies of Parkinson's Disease Contain Neurofilament Antigens
Goldman, J. E., Yen, S.-H., Chiu, F.-C., & Peress, N. S. (1983) · Science · doi:10.1126/science.6308771 · Cited by 260
Lewy body-related ?-synucleinopathy in the aged human brain
Jellinger, K. A. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0138-7 · Cited by 256
Zhu, J., Guo, F., Shelburne, J., Watkins, S., & Chu, C. T. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00478.x · Cited by 255
Calcium homeostasis, selective vulnerability and Parkinson's disease
Chan, C. S., Gertler, T. S., & Surmeier, D. J. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.01.006 · Cited by 237
Microglial Expression of MHC Class II Increases in Normal Aging of Nonhuman Primates
Sheffield, L. G., & Berman, N. E. J. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00168-1 · Cited by 234
McNaught, K. S. P., Belizaire, R., Jenner, P., Olanow, C. W., & Isacson, O. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00296-3 · Cited by 232
Chapter 36: Astrocytes and Parkinson's disease
Forno, L. S., DeLanney, L. E., Irwin, I., Monte, D. D., & Langston, J. W. (1992) · Progress in Brain Research · doi:10.1016/s0079-6123(08)61770-7 · Cited by 230
Nurr1 in Parkinson's disease and related disorders
Chu, Y., Le, W., Kompoliti, K., Jankovic, J., Mufson, E. J., & Kordower, J. H. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.20828 · Cited by 224
Self-citationImmunochemical Analysis of Vesicular Monoamine Transporter (VMAT2) Protein in Parkinson's Disease
Miller, G. W., Erickson, J. D., Perez, J. T., Penland, S. N., Mash, D. C., Rye, D. B., & Levey, A. I. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.7008 · Cited by 215
Meredith, G. E., Totterdell, S., Petroske, E., Santa Cruz, K., Callison, R. C., & Lau, Y.-S. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03514-x · Cited by 212
Chauhan, N. B., Siegel, G. J., & Lee, J. M. (2001) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(01)00115-6 · Cited by 207
German, D. C., Dubach, M., Askari, S., Speciale, S. G., & Bowden, D. M. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90320-x · Cited by 200
Age‐related decreases in Nurr1 immunoreactivity in the human substantia nigra
Chu, Y., Kompoliti, K., Cochran, E. J., Mufson, E. J., & Kordower, J. H. (2002) · Journal of Comparative Neurology · doi:10.1002/cne.10261 · Cited by 199
Self-citationHaycock, J. W., Becker, L., Ang, L., Furukawa, Y., Hornykiewicz, O., & Kish, S. J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02017.x · Cited by 194
Selective Vulnerability of Dopaminergic Neurons to Microtubule Depolymerization
Ren, Y., Liu, W., Jiang, H., Jiang, Q., & Feng, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503483200 · Cited by 188
Morens, D. M., Davis, J. W., Grandinetti, A., Ross, G. W., Popper, J. S., & White, L. R. (1996) · Neurology · doi:10.1212/wnl.46.4.1044 · Cited by 184
Li, W., Lesuisse, C., Xu, Y., Troncoso, J. C., Price, D. L., & Lee, M. K. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1370-04.2004 · Cited by 178
Greene, J. G., Dingledine, R., & Greenamyre, J. T. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.10.003 · Cited by 174
Preservation of midbrain catecholaminergic neurons in very old human subjects
Kubis, N., Faucheux, B. A., Ransmayr, G. N., Damier, P., Duyckaerts, C. J., Hénin, D., Forette, B., Charpentier, Y. L., Hauw, J., Agid, Y., et al. (2000) · Brain · doi:10.1093/brain/123.2.366 · Cited by 165
CLINICAL RELEVANCE OF SPECIFIC IgG ANTIBODIES TO CARDIOLIPIN
Faux, J. A., Byron, M. A., & Chapel, H. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92069-2 · Cited by 165
Progressive Dopamine Neuron Loss in Parkinson's Disease: The Multiple Hit Hypothesis
Carvey, P. M., Punati, A., & Newman, M. B. (2006) · Cell Transplantation · doi:10.3727/000000006783981990 · Cited by 164
Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases
Gu, M., Owen, A. D., Toffa, S. E. K., Cooper, J. M., Dexter, D. T., Jenner, P., Marsden, C. D., & Schapira, A. H. V. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00095-1 · Cited by 164
Collier, T. J., Lipton, J., Daley, B. F., Palfi, S., Chu, Y., Sortwell, C., Bakay, R. A. E., Sladek, J. R., & Kordower, J. H. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.11.013 · Cited by 162
Self-citationSchneider, J. S., Yuwiler, A., & Markham, C. H. (1987) · Brain Research · doi:10.1016/0006-8993(87)90691-3 · Cited by 160
Zhu, J., Kulich, S. M., Oury, T. D., & Chu, C. T. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64487-2 · Cited by 153
Neurodegeneration in Normal Brain Aging and Disease
Thal, D. R., Del Tredici, K., & Braak, H. (2004) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2004.23.pe26 · Cited by 149
Parkinson Disease With Old-Age Onset
Diederich, N. J., Moore, C. G., Leurgans, S. E., Chmura, T. A., & Goetz, C. G. (2003) · Archives of Neurology · doi:10.1001/archneur.60.4.529 · Cited by 147
ON THE HISTOCHEMISTRY AND ULTRASTRUCTURE OF AGE PIGMENT.
Bl, S. (1964) · PubMed · Cited by 135
German, D. C., Nelson, E. L., Liang, C., Speciale, S. G., Sinton, C. M., & Sonsalla, P. K. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0041 · Cited by 132
Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression
Maingay, M., Romero‐Ramos, M., Carta, M., & Kirik, D. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.007 · Cited by 128
Aging and the nigrostriatal dopamine system: a non-human primate study.
Irwin, I., DeLanney, L. E., McNeill, T. H., Chan, P., Forno, L. S., Murphy, G. M., Monte, D. A. D., Sandy, M. S., & Jw, L. (1994) · PubMed · Cited by 125
Aging of the nigrostriatal system in the squirrel monkey
McCormack, A. L., Monte, D. A. D., Delfani, K., Irwin, I., DeLanney, L. E., Langston, J. W., & Janson, A. M. (2004) · The Journal of Comparative Neurology · doi:10.1002/cne.20036 · Cited by 120
Liang, C., Sinton, C. M., Sonsalla, P. K., & German, D. C. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0042 · Cited by 116
Proteasomal activity in brain differs between species and brain regions and changes with age.
Zeng, B.-Y., Medhurst, A. D., Jackson, M., Rose, S., & Jenner, P. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.01.008 · Cited by 113
Mitochondrial damage and intralysosomal degradation in cellular aging
Terman, A., Gustafsson, B., & Brunk, U. T. (2006) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2006.08.006 · Cited by 104
González‐Hernández, T., Barroso‐Chinea, P., Cruz‐Muros, I., Pérez-Delgado, M. D. M., & Rodríguez, M. (2004) · The Journal of Comparative Neurology · doi:10.1002/cne.20323 · Cited by 102
Changes in somatodendritic but not terminal dopamine regulation in aged rhesus monkeys
Gerhardt, G. A., Cass, W. A., Ai, Y., Zhang, Z., & Gash, D. M. (2001) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00684.x · Cited by 102
Muthane, U. B., Yasha, T. C., & Shankar, S. K. (1998) · Annals of Neurology · doi:10.1002/ana.410430304 · Cited by 97
Villar‐Cheda, B., Rodríguez‐Pallares, J., Valenzuela, R., Muñoz, A., Guerra, M. J., Baltatu, O. C., & Labandeira-García, J. L. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07448.x · Cited by 92
The need for multiple time points in aging studies
Coleman, P. A., Finch, C. E., & Joseph, J. A. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.10.001 · Cited by 91
Asanuma, M., Miyazaki, I., Diaz-Corrales, F. J. J., & Ogawa, N. (2004) · PubMed · doi:10.18926/amo/32105 · Cited by 90
Age at onset: the major determinant of outcome in Parkinson's disease
Hely, M. A., Morris, J. G., Reid, W., O'Sullivan, D. J., Williamson, P. M., Broe, G. A., & ADENA, M. A. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1995.tb00480.x · Cited by 88
Kanaan, N. M., Kordower, J. H., & Collier, T. J. (2007) · The Journal of Comparative Neurology · doi:10.1002/cne.21333 · Cited by 83
Self-citationMotor Slowing and Parkinsonian Signs in Aging Rhesus Monkeys Mirror Human Aging
Zhang, Z., Andersen, A. H., Smith, C., Grondin, R., Gerhardt, G. A., & Gash, D. M. (2000) · The Journals of Gerontology Series A · doi:10.1093/gerona/55.10.b473 · Cited by 82
Age-related changes in glial cells of dopamine midbrain subregions in rhesus monkeys
Kanaan, N. M., Kordower, J. H., & Collier, T. J. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.07.006 · Cited by 80
Self-citationAlladi, P. A., Mahadevan, A., Yasha, T. C., Raju, T. R., Shankar, S. K., & Muthane, U. B. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.11.051 · Cited by 76
Hornykiewicz, O. (1989) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(89)90121-8 · Cited by 71
Ji, K., Eu, M. Y., Kang, S., Gwag, B. J., Jou, I., & Joe, E.-H. (2008) · Glia · doi:10.1002/glia.20677 · Cited by 71
Wang, H., & Morales, M. (2008) · The Journal of Comparative Neurology · doi:10.1002/cne.21751 · Cited by 69
Age-associated changes in rhesus CNS composition identified by MRI
Andersen, A. H., Zhang, Z., Zhang, M., Gash, D. M., & Avison, M. J. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01343-8 · Cited by 68
Beach, T. G., Walker, D. G., Sue, L. I., Newell, A., Adler, C., & Joyce, J. N. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.4.329 · Cited by 67
Kanaan, N. M., Kordower, J. H., & Collier, T. J. (2008) · Glia · doi:10.1002/glia.20690 · Cited by 67
Self-citationElsworth, J. D., Deutch, A. Y., Redmond, D. E., Sladek, J. R., & Roth, R. H. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90359-6 · Cited by 67
Kästner, A., Hirsch, É. C., Herrero, M. T., Javoy-Agid, F., & Agid, Y. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03616.x · Cited by 64
The Effect of Aging on Pars Compacta of the Substantia Nigra in Rhesus Monkey
Siddiqi, Z. A., & Peters, A. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199909000-00002 · Cited by 56
Kanaan, N. M., Kordower, J. H., & Collier, T. J. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06307.x · Cited by 49
Self-citationConsequences of impaired purine recycling in dopaminergic neurons
Lewers, J. C., Ceballos-Picot, I., Shirley, T. L., Mockel, L., Egami, K., & Jinnah, H. A. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2007.10.065 · Cited by 47
Dopamine neurotoxicity: age-dependent behavioral and histological effects
Cantuti‐Castelvetri, I., Shukitt‐Hale, B., & Joseph, J. A. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00186-0 · Cited by 46
Preferential vulnerability of mesencephalic dopamine neurons to glutamate transporter dysfunction
Nafia, I., Ré, D. B., Masmejean, F., Melon, C., Kachidian, P., Goff, L. K., Nieoullon, A. L., & Had‐Aissouni, L. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05146.x · Cited by 44
A stereological study of substantia nigra in young and old rhesus monkeys
Pakkenberg, H., Andersen, B. B., Burns, R. S., & Pakkenberg, B. (1995) · Brain Research · doi:10.1016/0006-8993(95)00678-j · Cited by 44
Susceptibility of ascending dopamine projections to 6-hydroxydopamine in rats: effect of hypothermia
Grant, R. J., & Clarke, P. B. S. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00385-8 · Cited by 26
Altered lipofuscin pigmentation in the basal nucleus (Meynert) in Parkinson's disease
Ulfig, N. (1989) · Neuroscience Research · doi:10.1016/0168-0102(89)90007-2 · Cited by 18
Mitochondrial energy crisis in Parkinson's disease.
Mizuno, Y., Ikebe, S., Hattori, N., Kondo, T., Tanaka, M., & Ozawa, T. (1993) · PubMed · Cited by 15
Parkinson's Disease: Symptoms and Age Dependency
Eshuis, S. A., & Leenders, K. L. (2001) · Elsevier eBooks · doi:10.1016/b978-012351830-9/50049-4 · Cited by 7
The Basal Ganglia Dopaminergic Systems in Normal Aging and Parkinson's Disease
Joyce, J. N. (2001) · Elsevier eBooks · doi:10.1016/b978-012351830-9/50050-0 · Cited by 6
Cited by
The Role of Oxidative Stress in Parkinson's Disease
Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845
Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States
Mattson, M. P., & Arumugam, T. V. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.05.011 · Cited by 1,242
Selective neuronal vulnerability in Parkinson disease
Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.178 · Cited by 1,116
Savelieff, M. G., Nam, G., Kang, J., Lee, H. J., Lee, M., & Lim, M. H. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00138 · Cited by 581
Disruption of mitochondrial complex I induces progressive parkinsonism
González-Rodríguez, P., Zampese, E., Stout, K. A., Guzman, J. N., Ilijic, E., Yang, B., Tkatch, T., Stavarache, M. A., Wokosin, D. L., Gao, L., et al. (2021) · Nature · doi:10.1038/s41586-021-04059-0 · Cited by 546
Metadata
- Authors
- Collier, T. J., Kanaan, N. M., & Kordower, J. H.
- Venue
- Nature Reviews Neuroscience
- Published
- 2011-05-18
- Volume
- 12
- Issue
- 6
- Pages
- 359-366
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2024173595
- Cited by
- 449
- References
- 121
- FWCI
- 2.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.